| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 147 |
| 1 | METHOTREXATE SODIUM | 118 |
| 2 | ACETAMINOPHEN | 114 |
| 3 | ETANERCEPT | 114 |
| 4 | GABAPENTIN | 114 |
| 5 | INFLIXIMAB | 110 |
| 6 | TOCILIZUMAB | 110 |
| 7 | ABATACEPT | 109 |
| 8 | PREDNISONE | 109 |
| 9 | METHOTREXATE | 108 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DESOXIMETASONE | 98 | 0.0051 |
| 1 | GOLIMUMAB | 60 | 0.0048 |
| 2 | CETIRIZINE HYDROCHLORIDE TABLETS | 98 | 0.0031 |
| 3 | DARIDOREXANT | 6 | 0.0022 |
| 4 | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 11 | 0.0018 |
| 5 | MAGNESIUM CITRATE ORAL SOLUTION | 11 | 0.0018 |
| 6 | MAGNESIUM CITRATE | 11 | 0.0017 |
| 7 | HYDROCORTISONE BUTYRATE | 3 | 0.0015 |
| 8 | HYDROXYCHLOROQUINE SULFATE | 102 | 0.0011 |
| 9 | TOFACITINIB CITRATE | 13 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 122 |
| 1 | Corticosteroid [EPC] | 121 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 121 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 111 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 110 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 109 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 108 |
| 7 | Antirheumatic Agent [EPC] | 69 |
| 8 | Aminosalicylate [EPC] | 40 |
| 9 | Benzodiazepine [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Receptor Antagonist [EPC] | 110 | 0.0008 |
| 1 | Selective T Cell Costimulation Modulator [EPC] | 109 | 0.0008 |
| 2 | Antirheumatic Agent [EPC] | 69 | 0.0007 |
| 3 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 4 | Nitrofuran Antibacterial [EPC] | 9 | 0.0005 |
| 5 | Aminosalicylate [EPC] | 40 | 0.0004 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 111 | 0.0004 |
| 7 | Progesterone [EPC] | 8 | 0.0003 |
| 8 | Orexin Receptor Antagonist [EPC] | 6 | 0.0003 |
| 9 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |